ILSI-Biomed Israel

OrSense Receives FDA Approval for Non-Invasive Oximetry Monitoring System

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, announced it has received U.S. Food and Drug Administration (FDA) approval for NBM-200MP, a non-invasive oximetry and low signal oximetry sensor.   Non-invasive pulse oximetry has become a standard of care in the operating and recovery rooms, intensive care units and emergency services, yet it has been known to provide erroneous oxygen saturation readings in situations of low perfusion, low...

Meet the Speakers: Prof. Mauro Ferrari on Individualized Medicine

Prof. Mauro Ferrari will give a keynote lecture in the up-and-coming ILSI-BioMed week, regarding the ways in which Nanotechnology Enables Individualized Medicine A friend of mine came to me recently with an interesting question. Both he and his wife suffer from headaches, and while he can take a single tablet of acamol to make the pain go away, his wife is almost unaffected by the tablets, which makes her quite grouchy – and leads in turn to him having an headache again. Why is that? A...

Digital Quantitative Pathology – Methods and Applications

הרינו מתכבדים להזמינכם לסמינר הרביעי של מכון לגסי הריטג' למחקר רפואי: Lecture topic: Edmond Sabo_Legacy Heritage Seminar4 2010 02 24 " פתולוגיה דיגיטלית כמותית – שיטות יישומים" ד"ר אדמונד סבו, המכון לפתולוגיה, חבר מכון לגסי הריטג' למחקר רפואי ברמב"ם ההרצאה תתקיים באולם הקתדרלה בבניין האבן ברמב"ם, בתאריך 24 פברואר 2010 בשעה 13:30. ביוזמת הנהלת רמב"ם וקרן לגסי הריטג' הוחל בחודש ספטמבר 2008 בהקמתו של מכון למחקר רפואי ייחודי מסוגו בארץ. מטרת מכון לגסי הריטג' היא להגיע לתגליות רפואיות בעלו...

Evolution in the Hospitals – How to Stop It?

Pathogens are constantly developing and evolving immunities to antibiotics, especially in the hospitals. Can we halt the course of evolution? A friend of mine, who also happens to be a medical doctor, got injured in an accident a few weeks ago and was hospitalized with an open fracture in his knee. Unfortunately, the wound got infected, and perhaps unsurprisingly – with germs who were resistant to the more common antibiotics in use. If you’re fearful for my friend’s health, you can relax ...

Start-up Weekly: MGVS – a Israeli Cell / Gene Therapy Company

MGVS is a promising Israeli company, whose leading product has passed Phase I/II trial in December 2009 and could be used to treat critical limb ischemia. PLUS they're currently recruiting! Name: MGVS Ltd. CEO: Guy Yachin Sector: Biotechnology Suc-Sector: Cell therapy Medical Field: Cardiovascular Est.: 2000 Stage: Phase I/IIa Clinical trials Vision: To become the leader in advanced cell therapy based solutions for cardiovascular patients Employees: 21 and currentl...

Nanodrop Vs. Regular Spectrophotometer ?

A low-budget Youtube commercial for a Nanodrop spectrophotometer gives back its money worth - and much more Kindly watch the below video. It opens up slow, and it goes on even slower, but... well, it's only three minutes!     So what do we have here? Two nerdy looking scientists, having a painfully-mock argument about the virtues of the Nanodrop spectrophotometer as opposed to using the old fashioned spectrophotometer. Let me stress that I'm all for the Nanodrop device, as it tru...

Asthma Relief Inhalers Might Make Asthma Worse?

A new study at the University of Leicester is probing why asthma relief inhalers might actually make asthma worse - and what can be done about it Ever since the industrial revolution, asthma has become one of the most common medical conditions in the world, with an estimated 300 million people suffering from the condition worldwide. Being an asthmatic myself, I know that currently there is no cure for asthma, although there are 'relievers' – usually inhalers that relieve asthma symptoms by re...

A New Promise for High-Speed Genetic Sequencing

A new promise for high-speed genetic sequencing by threading DNA segments through carbon nanotubes was revealed in Science this week The Human Genome Project was first launched in 1990 by the US government, and a working draft of the genome was issued ten years later. At 1998, a similar venture was launched by Craig Venter and his firm Celera Genomics, who made use of a faster sequencing method to reach an initial working draft in only two years. It’s clear that genetic sequencing technol...

Almost-Breakthroughs of the Year: Genetic Engineering and Longevity Drug

The magazine Science picked two runner-ups for the Breakthrough of the Year award: genetic engineering and a novel longevity drug Do you read Science, the magazine? You really should. It's one of the best sources for breakthroughs in research. This month they have a special section, where they tried to pick the Breakthrough of the Year. They probably had to do quite a lot of thinking, but eventually they settles on the discovery of Ardi - the missing link between our ancient ape-like ance...

The First Scientific Agreement between Japan and Israel

Researchers from the Technion and Japan will collaborate to develop a platform for the creation of blood vessels and cells from embryonic stem cells. Prime Minister Binyamin Netanyau said last week that the children of Israel should study Chinese as well as English. Personally, I would like to see more Israeli children doing the final exams, but I agree with his general approach. It's pretty obvious that the market is heading east: to India, China and Japan. And it's just as obvious that ...